In addition, this study demonstrated that CASC2 affects thyroid cancer cell invasion and metastasis by regulating the EMT pathway, and may be a predictor of LNM in patients with thyroid cancer. The gene discussed is CASC2; the disease is thyroid gland carcinoma.